Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 154.9 HKD -0.64% Market Closed
Market Cap: 211.1B HKD

Relative Value

The Relative Value of one Beigene Ltd stock under the Base Case scenario is 281.95 HKD. Compared to the current market price of 154.9 HKD, Beigene Ltd is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
281.95 HKD
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
47
Median 3Y
9.1
Median 5Y
7.8
Industry
6.9
Forward
5.3
vs History
vs Industry
Median 3Y
-18.1
Median 5Y
-20.3
Industry
23
Forward
368
vs History
3
vs Industry
Median 3Y
-17.4
Median 5Y
-21.4
Industry
19.7
vs History
vs Industry
Median 3Y
-13.9
Median 5Y
-17.7
Industry
22.8
vs History
14
vs Industry
11
Median 3Y
5.3
Median 5Y
4.9
Industry
2.6
vs History
57
vs Industry
40
Median 3Y
7.9
Median 5Y
7.2
Industry
7.4
Forward
5
vs History
57
vs Industry
41
Median 3Y
9.4
Median 5Y
8.6
Industry
9.3
vs History
vs Industry
23
Median 3Y
-13
Median 5Y
-14.5
Industry
4.1
Forward
106.3
vs History
vs Industry
21
Median 3Y
-13
Median 5Y
-14.5
Industry
4.1
Forward
412.2
vs History
3
vs Industry
23
Median 3Y
-15.2
Median 5Y
-18.7
Industry
4.9
vs History
vs Industry
22
Median 3Y
-10.9
Median 5Y
-14.5
Industry
3.6
vs History
26
vs Industry
19
Median 3Y
8
Median 5Y
7.1
Industry
4.7

Multiples Across Competitors

Competitors Multiples
Beigene Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beigene Ltd
HKEX:6160
214.9B HKD 6.6 -62.2 -82.5 -82.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 726 477.3 -165 049.8 -200 423.1 -198 136
US
Abbvie Inc
NYSE:ABBV
331.1B USD 5.8 79.7 15.2 22.5
US
Amgen Inc
NASDAQ:AMGN
154.4B USD 4.5 26 14.1 23.2
US
Gilead Sciences Inc
NASDAQ:GILD
137.7B USD 4.8 23.1 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.5B USD 10.3 -115.8 24.6 25.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 028.7 -517.7 -563.7 -548.7
AU
CSL Ltd
ASX:CSL
117.6B AUD 5 27.8 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
52.3B USD 3.7 11.6 10.2 11.5
US
Seagen Inc
F:SGT
39.3B EUR 19.5 -59.9 -64.6 -58.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40B USD 17 -148.4 -664.4 -332.9
P/S Multiple
Revenue Growth P/S to Growth
CN
Beigene Ltd
HKEX:6160
Average P/S: 3 157 143.9
6.6
23%
0.3
FR
Pharnext SCA
OTC:PNEXF
34 726 477.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.5
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
10%
1
US
E
Epizyme Inc
F:EPE
2 028.7
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
3.7
5%
0.7
US
S
Seagen Inc
F:SGT
19.5
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17
29%
0.6
P/E Multiple
Earnings Growth PEG
CN
Beigene Ltd
HKEX:6160
Average P/E: 33.6
Negative Multiple: -62.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -165 049.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.7
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.1
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.7 N/A N/A
AU
CSL Ltd
ASX:CSL
27.8
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.6
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Beigene Ltd
HKEX:6160
Average EV/EBITDA: 15.2
Negative Multiple: -82.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -200 423.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.1
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.2
11%
0.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -664.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Beigene Ltd
HKEX:6160
Average EV/EBIT: 19.7
Negative Multiple: -82.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 136 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.5
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.2
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -548.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.5
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -332.9 N/A N/A